Chungbuk, South Korea

Jung Ok Ban

This inventor holds 1 USPTO granted patent. Top assignee: Chungbuk National University Industry-Academic Cooperation Foundation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jung Ok Ban. Retrieved from https://idiyas.com/inventor/jung-ok-ban

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jung Ok Ban: Innovator in Cancer Treatment

Introduction

Jung Ok Ban is a notable inventor based in Chungbuk, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions.

Latest Patents

Jung Ok Ban holds a patent for a pharmaceutical composition comprising thiacremonone for treating colon cancer. This invention relates to an anti-cancer composition that utilizes a sulfur-containing compound, thiacremonone, as its active ingredient. The active ingredient is known to induce the death of cancer cells by apoptosis through the specific inhibition of the activity of NF-κB. This composition can be effectively used in the treatment or prevention of cancer.

Career Highlights

Jung Ok Ban is affiliated with the Chungbuk National University Industry-Academic Cooperation Foundation. Her work in this institution has allowed her to focus on groundbreaking research that addresses critical health issues, particularly in oncology.

Collaborations

Some of her notable coworkers include Jin Tae Hong and Heon-Sang Jeong, who have collaborated with her on various research projects.

Conclusion

Jung Ok Ban's innovative work in developing anti-cancer compositions highlights her commitment to advancing medical science. Her contributions are paving the way for new treatment options for colon cancer, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…